Oracle loses executives health division as several senior leaders depart its health records unit following the Cerner acquisition.

The cloud computing competitor trades for a lower valuation than its bigger peers.

An Oppenheimer analyst has turned bullish on Oracle’s stock after a selloff that has wiped away more than half the company’s value since its September peak.

Oppenheimer believes that a sharp recent pullback in Oracle has created an attractive risk-reward balance for investors. The financial institution upgraded the tech old guard to an outperform rating ...

ORCL’s operating margin of 31.9% is substantial, but falls short of MSFT’s 46.7% because of Oracle’s extensive investment in cloud data center infrastructure. ORCL’s revenue growth of 11.1%, driven by ...

Oracle Corp. has begun laying the groundwork needed to start construction on its new headquarters in Nashville.

Red Bull Racing has moved decisively to reinforce the pillars of its success in the sport by extending its title partnership ...

Oracle’s (NYSE: ORCL) 2025 and 2026 stock price sell-off is monumental, creating a generational opportunity for investors. While concerns persist, the critical takeaway is that a robust outlook ...